Carbon Black Tinted Contact Lenses for Reduction of Photophobia in Cystinosis Patients

ABSTRACT Purpose: To examine if current development on using contact lenses for drug delivery of cysteamine to treat ocular symptoms of cystinosis can be tinted to mitigate photophobia common in patients by reducing transmittance Methods: Commercial contact lenses were placed in a carbon black solution to examine loading after lens synthesis. Silicone hydrogel contact lenses were also synthesized with carbon black added prior to UV curing. Transmittance was measured using UV–vis spectrophotometry over the range of 190–1190 nm and compared to unmodified contact lenses. Lens parameters of refractive index, ion permeability, and Young’s modulus were measured using a refractometer, release of sodium chloride, and the cantilever method. Cysteamine release was measured by loading lenses into 5% cysteamine solution and then monitoring the release of the drug using UV–vis spectrophotometry. Vitamin E diffusion barriers were also added to lenses via ethanol solution, and the release of cysteamine from these modified lenses was also examined. Results: No leeching of carbon black was detected during experiments. Loading of pre-made contact lenses led to uneven distribution of carbon black throughout lens. Adding 0.3% carbon black to lens monomer solution prior to UV-curing led to even distribution and a transmittance reduction of approximately 50%. Ion permeability was reduced from 6.19 ± 0.90 x 10−3 to 1.28 ± 0.06 x 10−3 mm2 min−1, and Young’s modulus was decreased from 1.58 ± 0.08 to 1.29 ± 0.06 MPa. Cysteamine releases from carbon black lenses with and without vitamin E were comparable to controls, although the loading solution of vitamin E/ethanol had to be tripled to achieve a similar mass loading to control. Conclusions: Carbon black increases the softness of contact lenses, but a loading of 0.3% maintains lens parameters required for wear. The release of cysteamine is also possible with carbon black lenses, albeit requiring a higher loading concentration of vitamin E to achieve similar release times.

[1]  A. Chauhan,et al.  Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation , 2018, Drug Delivery and Translational Research.

[2]  A. Chauhan,et al.  In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses , 2017, International journal of pharmaceutics.

[3]  K. Ehrmann,et al.  Mechanical Properties of Contact Lens Materials , 2017, Eye & contact lens.

[4]  R. Bishop Ocular Complications of Infantile Nephropathic Cystinosis , 2017, The Journal of pediatrics.

[5]  A. Chauhan,et al.  Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  W. Gahl,et al.  Cysteamine ophthalmic solution 0.44% for the treatment of corneal cystine crystals in cystinosis , 2013 .

[7]  Arijit Bose,et al.  The response of carbon black stabilized oil-in-water emulsions to the addition of surfactant solutions. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[8]  S. Cherqui Cysteamine therapy: a treatment for cystinosis, not a cure. , 2012, Kidney international.

[9]  Anuj Chauhan,et al.  Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. , 2010, Biomaterials.

[10]  L. P. Van den Heuvel,et al.  Analysis of CTNS gene transcripts in nephropathic cystinosis , 2010, Pediatric Nephrology.

[11]  Ying Chen,et al.  Antioxidant defenses in the ocular surface. , 2009, The ocular surface.

[12]  W. Gahl,et al.  Nephropathic cystinosis: late complications of a multisystemic disease , 2008, Pediatric Nephrology.

[13]  W. Gahl,et al.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. , 2007, Survey of ophthalmology.

[14]  J. Morrow,et al.  Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. , 2004, The Biochemical journal.

[15]  M. Gubler,et al.  Ocular changes in some progressive hereditary nephropathies , 1987, Pediatric Nephrology.

[16]  J. Dufier,et al.  Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine. , 2003, Journal of pediatric ophthalmology and strabismus.

[17]  W. Gahl,et al.  Cystinosis. , 2002, The New England journal of medicine.

[18]  C. Antignac,et al.  Cystinosin, the protein defective in cystinosis, is a H+‐driven lysosomal cystine transporter , 2001, The EMBO journal.

[19]  E. Kuehl,et al.  Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. , 2000, Molecular genetics and metabolism.

[20]  G. Mancini,et al.  Lysosomal transport disorders , 2000, Journal of Inherited Metabolic Disease.

[21]  M. Kaiser-Kupfer,et al.  Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations , 2000, Pediatric Research.

[22]  O. Gribouval,et al.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis , 1998, Nature Genetics.

[23]  S. Rhee,et al.  Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. L. Noble,et al.  Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%. , 1991, The British journal of ophthalmology.

[25]  M. Kaiser-Kupfer,et al.  Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. , 1987, The New England journal of medicine.

[26]  W. Gahl Cystinosis coming of age. , 1986, Advances in pediatrics.

[27]  W. Gahl,et al.  Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. , 1982, Science.

[28]  C. Duve,et al.  Functions of lysosomes. , 1966, Annual review of physiology.